Fürst Stirum Klinik Bruchsal
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Andrassy, Martin
NCT04859985: The SELUTION DeNovo Study

Active, not recruiting
N/A
3326
Europe, RoW
SELUTION SLR, DES
M.A. Med Alliance S.A.
Coronary Artery Disease
08/25
07/30
LIMES, NCT04772300: Trial to Assess the Safety and Efficacy of Sirolimus-Coated Balloon vs. Uncoated Standard Angioplasty for the Treatment of Below-the-knee Peripheral Arterial Disease

Recruiting
N/A
230
Europe
Percutaneous Transluminal Angioplasty (PTA) MagicTouch Sirolimus Coated PTA Balloon Catheter, Percutaneous Transluminal Angioplasty (PTA) with non-coated balloon catheter (POBA)
Jena University Hospital, Concept Medical Inc., Vascuscience, CoreLab Black Forest, Center for Clinical Studies, University Hospital Jena
Peripheral Artery Disease
12/27
09/28
ELEGANCE, NCT04674969: Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Recruiting
N/A
5000
Europe, Canada, US, RoW
Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device.
Boston Scientific Corporation
Peripheral Vascular Diseases
01/28
01/28
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Andrassy, Martin
NCT04859985: The SELUTION DeNovo Study

Active, not recruiting
N/A
3326
Europe, RoW
SELUTION SLR, DES
M.A. Med Alliance S.A.
Coronary Artery Disease
08/25
07/30
LIMES, NCT04772300: Trial to Assess the Safety and Efficacy of Sirolimus-Coated Balloon vs. Uncoated Standard Angioplasty for the Treatment of Below-the-knee Peripheral Arterial Disease

Recruiting
N/A
230
Europe
Percutaneous Transluminal Angioplasty (PTA) MagicTouch Sirolimus Coated PTA Balloon Catheter, Percutaneous Transluminal Angioplasty (PTA) with non-coated balloon catheter (POBA)
Jena University Hospital, Concept Medical Inc., Vascuscience, CoreLab Black Forest, Center for Clinical Studies, University Hospital Jena
Peripheral Artery Disease
12/27
09/28
ELEGANCE, NCT04674969: Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Recruiting
N/A
5000
Europe, Canada, US, RoW
Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device.
Boston Scientific Corporation
Peripheral Vascular Diseases
01/28
01/28

Download Options